AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Free Cash Flow (2020 - 2026)

AtaiBeckley (ATAI) posted Free Cash Flow of -$23.7 million for Q3 2025, down 66.35% sequentially from -$14.2 million in Q2 2025, and down 22.28% YoY from -$30.4 million in Q3 2024.

Analysis

AtaiBeckley (ATAI) Free Cash Flow (2020 - 2026) Analysis & Trends

AtaiBeckley's Free Cash Flow history runs 2 years deep, the most recent figure standing at -$21.1 million for Q1 2026.

  • In Q1 2026, Free Cash Flow fell 16.46% year-over-year to -$21.1 million; the TTM figure through Mar 2026 stood at -$39.2 million (changed N/A YoY), while the FY2025 annual figure was -$103.6 million, down 25.63% from the prior year.
  • Free Cash Flow declined to -$23.7 million in Q3 2025 per ATAI's latest filing, from -$14.2 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$18.1 million in Q1 2025, with the low at -$21.1 million in Q1 2026.
  • A 5-year average of -$20.6 million and a median of -$22.0 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2022 and 2023: Free Cash Flow sank 31956.0% in 2022, then soared 35.58% in 2023.
  • Over 5 years, Free Cash Flow stood at -$20.4 million in 2021, then tumbled by 50.16% to -$30.6 million in 2022, then climbed by 28.08% to -$22.0 million in 2023, then dropped by 10.22% to -$24.3 million in 2024, then increased by 2.63% to -$23.7 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$23.7 million, -$14.2 million, and -$18.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn - -23.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.27 Mn
Mar 31, 2026 -21.09 Mn
Sep 30, 2025 -23.66 Mn
Jun 30, 2025 -14.22 Mn
Jun 30, 2025 -14.22 Mn
Mar 31, 2025 -18.11 Mn
Mar 31, 2025 -18.11 Mn
Dec 31, 2024 -24.30 Mn
Sep 30, 2024 -19.34 Mn
Jun 30, 2024 -16.23 Mn
Mar 31, 2024 -22.58 Mn
Dec 31, 2023 -21.97 Mn
Sep 30, 2023 -18.43 Mn
Jun 30, 2023 -22.65 Mn
Mar 31, 2023 -21.39 Mn
Dec 31, 2022 -30.65 Mn
Sep 30, 2022 -28.50 Mn
Jun 30, 2022 -22.05 Mn
Mar 31, 2022 -24.04 Mn
Dec 31, 2021 -20.81 Mn